Maximize Compliance and Quality with ProPharma's Expert Support
Our expert team offers enhanced Quality Unit support, MIA and WDA licensing guidance, and GMP compliance, ensuring your products meet EU and UK regulations. Connect with a ProPharma expert today to maintain the highest levels of safety and consistency.
Qualified Person Services for EU and UK Markets
Companies that intend to manufacture or import medicinal products in the EU and UK require a Manufacturing and Import Authorization (MIA) license and a designated named Qualified Person (QP) to oversee the product quality throughout the supply chain. Acting as an extension of your organization, our QP consultants bring a deep understanding of GMP processes. They work with your tesam to ensure compliant manufacturing and/or importation of products in the EU and UK markets. Our global team of certified QPs have broad experience covering multiple types of formulations, complex supply chains, technical transfer projects, aseptic/sterile manufacturing, radiopharmaceuticals, biologics, ATMPs, and supply for clinical trials.
Navigating Regulatory Requirements for Medicinal Products
Every organization in the life sciences industry is required to have a current and compliant quality system to ensure the safety and quality of all products and services. Quality assurance involves upholding the desired level of quality in your products throughout every stage of the process, from production to delivery to the patient.
ProPharma's quality assurance professionals enhance your internal capabilities to ensure the consistency and safety of products. Our team acts as an extension of your Quality Unit, utilizing a hands-on and risk-based approach to quickly improve quality and compliance while implementing practical solutions for your organization.
Enhancing Quality with Qualified Person Services
To procure, sell and distribute medicinal products in the EU and the UK markets you need a Wholesaler Dealer Authorization (WDA) and a Responsible Person (RP) named on the license. In the UK a WDA can also be utilized to import QP-certified medicinal products from the EU. In that case, you would need a Responsible Person (import). The RP is tasked with supervising the quality of the company's wholesale operation and takes on the primary responsibility for ensuring compliance with GDP regulations and maintaining the quality of the distributed products.
Our highly experienced RPs can act as contractors named on your, or a third-party's, WDA for both human and veterinary medicines under EU and UK Guidelines. If you are new to the EU/UK market we can help you in navigating the road from QMS build, through the WDA application process, a successful inspection, and obtaining your very own WDA license.
Specialized QP/RP/RPi Services
ProPharma's global team of certified experts have broad experience covering multiple types of formulations, complex supply chains, technical transfer projects, aseptic/sterile manufacturing, radiopharmaceuticals, biologics, ATMP's, market access and supply for clinical trials.
Our QP/RP/RPi services include
Partnering with your organization to lead or assist in obtaining the manufacturer’s import license and wholesale distributor license
Providing strategic recommendations in addition to standard QP oversight. We will support your organization to reduce issues, delays, and costs in the manufacturing process
Helping organizations develop a flexible staffing model that caters to specific needs ranging from long-term lead assignments (named on the client's license) to interim support
QP Declaration
QP Confirmation
QP Batch Certification
Experience building Quality Management Systems (QMS) and providing full oversight of the QMS to maintain product quality in the distribution to pharmacies, hospitals, or other wholesalers
Supply chain mapping and risk assessment thereof to comply with the Falsified Medicines Directive 2011/62/EU
Experience in EU & UK
- Import and Batch Certification services for ATMPs, Biologics, Radiopharmaceuticals, vaccines and small molecules for both IMP and commercial products in EU.
- Import and Batch Certification services for commercial Oral Solid Dosage products. QP Oversight of all types of IMP imported to the UK from the EEA.
Support for Pharmaceutical Products & Services
Our QP/RP/RPi experts can support a variety of products for the pharmaceutical industry, including:
- Tablets
- Capsules, both hard and soft shell
- Liquids, creams, and ointments, both sterile and non-sterile
- Sterilization by filtration, irradiation, and ethylene oxide
- API supplier auditing, both small and large molecule to EU GMP Part II/ ICH Q7
- Excipient supplier auditing to IPEC-PQG guidelines
- Packaging supplies auditing, covering leaflets, labels, cartons, foils & films, primary containers to GMP, and PS9000:2016
- Contract analytical laboratory auditing to GMP and ISO 17025:2017
- Storage and distribution warehouse auditing to GDP
- ATMPs
- Biologics
- Radiopharmaceuticals
- Vaccines
- IMP
- Commercial products
Interim Qualified Person (QP)
Companies that intend to manufacture, import, sell or distribute pharmaceutical products in the EU/UK require a MIA license and a designated Qualified Person (QP) to oversee the product quality, and ultimately certify each batch of medicinal product for being manufactured, tested and released in accordance with EU GMP and the documents submitted to the EU/UK authorities.
In certain instances, volumes or circumstances may not justify hiring a QP. In such situations our QPs act as an extension of your organization, bringing a deep understanding of Good Manufacturing Practice (GMP) processes. They work with your team to ensure compliant manufacturing and distribution of products in the EU/UK market.
Interim Responsible Person (RP/RPi) Services
Wholesaling of Medicinal Products and Active Pharmaceutical Ingredients Under GDP
Our team of extensively skilled QPs and RPs is ready to function as contractors listed on your or a third parties Wholesale Dealers Authorization for both human and veterinary medicines under European Guidelines 2013/C 343/01 human medicines and 2015/C 95/01 APIs for medicinal products for human use.
How to Successfully Launch Products with QMS and QP Certification
Reaching patients in the EU with needed medicinal products is a complex undertaking that not only requires knowledge of varied regulatory landscapes, companies must also man, the services of a...
Ensure Successful Batch Release, Regulatory Compliance with Experienced Qualified Persons
Streamlining a CMO’s manufacturing process helped ensure GMP compliance for EU batch release and USA inspection readiness. A contract manufacturing organization (CMO) needs to have a reliable quality...
Insider Talks - Tips From Qualified Persons for Successful Importation
Which are the roadblocks impacting successfully obtaining a MIA for EEA/UK Markets? You are in the process of obtaining an MA or CTA to bring your product to EEA/UK markets, which can be a complex...
News & Insights
August 7, 2025
Orchestrating Excellence: How ProPharma Bridges Vendors to Deliver Unified, High...
Discover how ProPharma enhances collaboration and quality in drug development by expertly coordinating and communicating with multiple vendors for unified, high-quality outcomes.
August 4, 2025
European Marketing Authorization Success: The Critical Role of Quality and Compl...
Achieve European market success with robust quality and compliance solutions, ensuring seamless market entry and long-term growth through expert QP support
July 31, 2025
Pros and Cons of Working with a CRO
Explore the pros and cons of working with a Contract Research Organization (CRO) and how ProPharma sets a new standard in clinical development success.
.png?width=320&height=185&name=Global%20MLR%20Review%20(RS).png)
.png?width=320&height=185&name=Obesity%20%E2%80%93%20Accelerated%20Timelines%20(1).png)
.png?width=320&height=185&name=labeling-webinar-thumbnail%20(1).png)
News & Insights
July 8, 2025
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma Recognized for AI Excellence at ECCCSA
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
